Education
About Us
Working with TipRanks
Follow Us
Charles River Laboratories Intl (CRL)
NYSE:CRL
CRL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$91.86 - $254.15
Previous CloseN/A
Volume179.29K
Average Volume (3M)1.15M
Market Cap
$7.42B
Enterprise Value$13.94B
Total Cash (Recent Filing)$229.36M
Total Debt (Recent Filing)$2.99B
Price to Earnings (P/E)449.9
Beta0.75
Next Earnings
Jul 30, 2025EPS Estimate
2.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.34
Shares Outstanding49,115,710
10 Day Avg. Volume732,323
30 Day Avg. Volume1,149,193
Financial Highlights & Ratios
PEG Ratio0.98
Price to Book (P/B)3.72
Price to Sales (P/S)0.00
P/FCF Ratio37.54
Enterprise Value/Market Cap1.88
Enterprise Value/Revenue0.86
Enterprise Value/Gross Profit10.88
Enterprise Value/Ebitda4.46
Forecast
1Y Price Target
$157.23Price Target Upside3.52% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
Charles River Labs News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceCharles River Laboratories reported a strong first-quarter performance with better-than-expected results in DSA and RMS.
Strategic InitiativesThe company is focusing on preclinical demand trends, which indicates a strategic approach to maintaining growth.
ValuationValuation is significantly lower than the 5-year average, suggesting substantial upside potential.
Bears Say
Funding ConcernsConcerns about funding for A&G could pose a challenge, though they have minimal near-term impact from the phase-out of animal testing.
Macro PressureDSA/RMS are exposed to macro pressure and FDA's animal testing plans.
Regulatory ConcernsThere is some concern about the shift away from animal testing, which could impact certain operations.
Ownership Overview
0.90% Insiders
33.09% Mutual Funds
27.74% Other Institutional Investors
11.69% Public Companies and Individual Investors
CRL FAQ
What was Charles River Laboratories Intl’s price range in the past 12 months?
Charles River Laboratories Intl lowest stock price was $91.86 and its highest was $254.15 in the past 12 months.
What is Charles River Laboratories Intl’s market cap?
Charles River Laboratories Intl’s market cap is $7.42B.
When is Charles River Laboratories Intl’s upcoming earnings report date?
Charles River Laboratories Intl’s upcoming earnings report date is Jul 30, 2025 which is in 46 days.
How were Charles River Laboratories Intl’s earnings last quarter?
Charles River Laboratories Intl released its earnings results on May 07, 2025. The company reported $2.34 earnings per share for the quarter, beating the consensus estimate of $2.076 by $0.264.
Is Charles River Laboratories Intl overvalued?
According to Wall Street analysts Charles River Laboratories Intl’s price is currently Undervalued.
Does Charles River Laboratories Intl pay dividends?
Charles River Laboratories Intl does not currently pay dividends.
What is Charles River Laboratories Intl’s EPS estimate?
Charles River Laboratories Intl’s EPS estimate is 2.5.
How many shares outstanding does Charles River Laboratories Intl have?
Charles River Laboratories Intl has 49,115,710 shares outstanding.
What happened to Charles River Laboratories Intl’s price movement after its last earnings report?
Charles River Laboratories Intl reported an EPS of $2.34 in its last earnings report, beating expectations of $2.076. Following the earnings report the stock price went up 18.681%.
Which hedge fund is a major shareholder of Charles River Laboratories Intl?
Currently, no hedge funds are holding shares in CRL
Charles River Labs Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$157.23 (3.52% Upside)
$157.23 (3.52% Upside)
Blogger Sentiment
Neutral
CRL Sentiment 50%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 262.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $72.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.4%
Last 30 Days ▲ 4.3%
Last 30 Days ▲ 4.3%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.97%
12-Months-Change
Fundamentals
Return on Equity
-0.92%
Trailing 12-Months
Asset Growth
-7.00%
Trailing 12-Months
Company Description
Charles River Laboratories Intl
Charles River Laboratories International, Inc. (CRL) is a leading global contract research organization (CRO) that provides essential products and services to accelerate research and drug development efforts. The company operates in various sectors, including research models and services, discovery and safety assessment, and manufacturing support. Its core offerings include research models, preclinical and clinical laboratory services, and biologics testing solutions, primarily catering to the pharmaceutical, biotechnology, and academic sectors.
CRL Company Deck
CRL Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a cautious yet optimistic outlook, with strong cost management and improved DSA performance offsetting revenue declines across segments. While there are concerns about NIH funding and challenges in the Manufacturing segment, the company is optimistic about strategic investments and increased guidance.Read More>CRL Revenue Breakdown
60.53% DSA
20.48% RMS
19.00% Manufacturing
CRL Stock 12 Month Forecast
Average Price Target
$157.23
▲(3.52%Upside)